Menopausal hormone therapy and mortality: A systematic review and meta-analysis

Khalid Benkhadra, Khaled Mohammed, Alaa Al Nofal, Barbara G. Carranza Leon, Fares Alahdab, Stephanie Faubion, Victor Manuel Montori, Abd Moain Abu Dabrh, Jorge Alberto Zúñiga Hernández, Larry J. Prokop, Mohammad H Murad

Research output: Contribution to journalArticle

28 Scopus citations

Abstract

Objectives: The objective was to assess the effect of menopausal hormonal therapy (MHT) on all-cause and cause-specific mortality. Methods: We conducted a comprehensive search of several databases (MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials and Database of Systematic Reviews, and Scopus) from inception until August 2013. We included randomized controlled trials (RCTs) of more than 6 months of duration comparing MHT with no treatment. Pairs of independent reviewers selected trials, assessed risk of bias and extracted data. We estimated risk ratios (RRs) and 95% confidence intervals (CIs) using the random-effects model. Results:Weincluded 43 RCTs at moderate risk of bias. Meta-analysis showed no effect on mortality (RR 0.99[95%CI, 0.94-1.05]), regardless ofMHTtype or history of preexisting heart disease.Noassociation was found between MHT and cardiac death (RR 1.04 [95% CI 0.87-1.23]) or stroke (RR 1.49 [95% CI 0.95-2.31]). Estrogen plus progesterone use was associated with a likely increase in breast cancer mortality (RR 1.96[95%CI 0.98-3.94]),whereasestrogen usewasnot.MHTusewasnot associated with mortality of other types of cancer. In 5 trials,MHTwaslikely started at a younger age: 2 RCTs withmean agelessthan60and3RCTswithMHTstarted lessthan10years aftermenopause.Meta-analysis of these 5 RCTs showed a reduction of mortality with MHT (RR 0.70 [95% CI 0.52-0.95]). Conclusion: The current evidence suggests that MHT does not affect the risk of death from all causes, cardiac death and death from stroke or cancer. These data may be used to support clinical and policy deliberations about the role of MHT in the care of symptomatic postmenopausal women.

Original languageEnglish (US)
Pages (from-to)4021-4028
Number of pages8
JournalJournal of Clinical Endocrinology and Metabolism
Volume100
Issue number11
DOIs
StatePublished - Nov 1 2015

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Menopausal hormone therapy and mortality: A systematic review and meta-analysis'. Together they form a unique fingerprint.

  • Cite this

    Benkhadra, K., Mohammed, K., Al Nofal, A., Carranza Leon, B. G., Alahdab, F., Faubion, S., Montori, V. M., Abu Dabrh, A. M., Hernández, J. A. Z., Prokop, L. J., & Murad, M. H. (2015). Menopausal hormone therapy and mortality: A systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism, 100(11), 4021-4028. https://doi.org/10.1210/jc.2015-2238